Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SSY GroupLJUIF 86 Gross Margin % is 41.65% as of Dec. 2025, which is 27% below its 10-year median of 57.38. GuruFocus rates LJUIF with a GF Score™ of 86/100 and a GF Value™ of $0.51. The stock has 8 warning signs investors should review. Among 942 Drug Manufacturers companies, SSY Group ranks worse than 62.31% on this metric.
Gross Margin % is calculated as gross profit divided by its revenue. SSY Group's Gross Profit for the
six
months ended in Dec. 2025 was $108.0 Mil. SSY Group's Revenue for the
six
months ended in Dec. 2025 was $259.4 Mil. Therefore, SSY Group's Gross Margin % for the quarter that ended in Dec. 2025 was 41.65%.
Warning Sign:
SSY Group Ltd gross margin has been in long-term decline. The average rate of decline per year is -7.2%.
The historical rank and industry rank for SSY Group's Gross Margin % or its related term are showing as below:
LJUIF'
s Gross Margin % Range Over the Past 10 Years
Min: 41.56 Med: 57.38 Max: 63.56
Current: 41.56
During the past 13 years, the highestGross Margin % of SSY Group was 63.56%. The lowest was 41.56%. And the median was 57.38%.
LJUIF's Gross Margin % is ranked worse than 62.31% of 942
companies
in the Drug Manufacturers industry
Industry Median: 48.54
vs LJUIF: 41.56
SSY Group had a gross margin of 41.65% for the quarter that ended in Dec. 2025 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for SSY Group was -7.20% per year.
SSY Group (OTCPK:LJUIF) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
SSY Group had a gross margin of 41.65% for the quarter that ended in Dec. 2025 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
SSY Group Gross Margin % Related Terms
SSY Group Gross Margin % Historical Data
* Premium members only.
The historical data trend for SSY Group's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, SSY Group's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SSY Group Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, SSY Group's Gross Margin % distribution charts can be found below:
* The bar in red indicates where SSY Group's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
SSY Group (LJUIF) has a Gross Margin % of 41.65% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on SSY Group and its competitors. This is 27% below median its historical median of 57.38. Over the past decade, SSY Group's Gross Margin % has ranged from 41.56 to 63.56. According to the industry distribution chart, SSY Group ranks #587 out of 942 companies in the Drug Manufacturers industry, placing it in the top 62.3%.
Is SSY Group's Gross Margin % too high?
SSY Group's current Gross Margin % of 41.65% is 27% below median its 10-year median of 57.38. Over the past 10 years, this metric has ranged from a low of 41.56 to a high of 63.56. The Drug Manufacturers industry median Gross Margin % is 48.54. SSY Group's value of 41.65% is 14.2% below this industry median. Based on the distribution chart, SSY Group ranks #587 out of 942 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, SSY Group has a GF Score™ of 86/100, reflecting its overall financial health beyond just this single metric.
How does SSY Group's Gross Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, SSY Group ranks #587 out of 942 companies for Gross Margin %. This places SSY Group in the lower half of its industry. The industry median Gross Margin % is 48.54. SSY Group's value of 41.65% is 14.2% below this benchmark. Historically, SSY Group's own Gross Margin % has ranged from 41.56 to 63.56 over the past decade. While the company's 10-year median is 57.38 vs. the industry median of 48.54, SSY Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.54, based on 942 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SSY Group's current Gross Margin % of 41.65% is 14.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on SSY Group and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SSY Group's current Gross Margin % is 41.65%, which is 27% below median its own 10-year median of 57.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SSY Group stock overvalued right now?
SSY Group (LJUIF) has a current Gross Margin % of 41.65%. The stock's GF Value™ is $0.51, compared to a current price of $0.40 — trading 21.1% below its estimated fair value. The current Gross Margin % is 41.65%, which is 27% below median its 10-year median of 57.38 and 14.2% below the Drug Manufacturers industry median of 48.54. SSY Group's overall GF Score™ is 86/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For SSY Group (LJUIF), the current Gross Margin % is 41.65% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SSY Group (LJUIF) Overvalued in 2026?
Based on GuruFocus' analysis, SSY Group stock appears to be undervalued.
The current stock price of $0.40 is trading 21.1% below its estimated GF Value™ of $0.51.
Key valuation signals for LJUIF:
Gross Margin %: 41.65% (27% below median its 10-year median of 57.38)
GF Value™: $0.51 vs. price of $0.40 (21.1% below fair value)
Industry Position: 14.2% below the Drug Manufacturers median (#587 of 942)
No single metric tells the full story. See the LJUIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SSY Group Ltd is engaged in the research, development, manufacturing, and selling of a wide range of pharmaceutical products, which include finished medicines of mainly intravenous infusion solutions and ampoule injections to hospitals and distributors, bulk pharmaceuticals, and medical materials. The company has two reportable segments, including intravenous infusion solutions and other medical materials. The company derives a vast majority of its revenue principally from the Intravenous infusion solution and others. Revenue generation is driven mostly by its sales of pharmaceutical products. The company derives maximum revenue from PRC.
86GF Score
Get the complete analysis for LJUIF
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LJUIF has been successfully added to your 
